The plant will make life saving vaccines. Not only is that a first of its kind facility and an economic boost in Holly springs, it also will be a boost in the fight against the flu.
Instead of using eggs, the Novartis site is the first cell=based vaccine plant in the U.S., making it a major player in the fight against future pandemics. Workers will help create 150 million doses of much needed vaccine within a six month period.
That work won't happen in enough time to meet the current high demand for the H1N1 vaccine, but the plant will specialize in a type of technology that makes vaccines more effective.
The Novartis plant comes with a $1 billion price tag -- half of it paid with federal money.
It's a worthy expense some say could help in the fight against potentially life-threatening pandemics like HIN1.